Home / Inspections / 1316966

FDA Inspection 1316966 — Reproductive Medicine Institute

Reproductive Medicine Institute — FEI 3009383018

The FDA completed an inspection of Reproductive Medicine Institute on May 12, 2026 in Chicago, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
May 12, 2026
Fiscal Year
2026
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Chicago, IL (United States)

Facility

Other inspections at this facility

  • 1216225 (NAI Wed Aug 16 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1054441 (NAI Tue May 08 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 973314 (NAI Fri May 27 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 900067 (NAI Thu Oct 16 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 811049 (NAI Thu Dec 20 2012 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources